Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Privacy



Stock Trading History of Zante Greg

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Zante Greg since year 2005. The trader's CIK number is 1264949. At the time of this reporting, Zante Greg is the VP, Finance & Administration of Sangamo Biosciences Inc . (stock ticker symbol SGMO). See this page for all insider trading activities at Sangamo Biosciences Inc .

Stock purchases, sales, and option exercises reported by insider Zante Greg since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-02-14 SGMO Sangamo Biosciences Inc Sale 100 12.00 1,200
2008-02-14 SGMO Sangamo Biosciences Inc Option Exercise 100 4.11 411
2008-02-14 SGMO Sangamo Biosciences Inc Sale 5,000 12.01 60,050
2008-02-14 SGMO Sangamo Biosciences Inc Option Exercise 5,000 4.65 23,250
2008-01-08 SGMO Sangamo Biosciences Inc Option Exercise 5,000 4.74 23,700
2008-01-08 SGMO Sangamo Biosciences Inc Sale 5,000 12.77 63,850
2007-12-07 SGMO Sangamo Biosciences Inc Option Exercise 5,000 4.52 22,575
2007-12-07 SGMO Sangamo Biosciences Inc Sale 5,000 15.74 78,677
2007-11-08 SGMO Sangamo Biosciences Inc Option Exercise 11,858 3.56 42,155
2007-11-08 SGMO Sangamo Biosciences Inc Sale 12,500 18.03 225,375
2006-12-11 SGMO Sangamo Biosciences Inc Option Exercise 27,417 4.37 119,812
2006-12-12 SGMO Sangamo Biosciences Inc Option Exercise 12,500 4.11 51,375
2006-12-11 SGMO Sangamo Biosciences Inc Sale 27,417 7.04 193,015
2006-12-12 SGMO Sangamo Biosciences Inc Sale 12,500 6.98 87,250
2006-06-01 SGMO Sangamo Biosciences Inc Option Exercise 8,000 3.00 24,000
2006-06-01 SGMO Sangamo Biosciences Inc Sale 8,000 7.90 63,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zante Greg (VP, Finance & Administration of Sangamo Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.